SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-20-010724
Filing Date
2020-05-05
Accepted
2020-05-05 16:21:22
Documents
76
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10q.htm 10-Q 711711
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 11536
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 11154
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 5163
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 5148
  Complete submission text file 0001140361-20-010724.txt   4574654

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aqst-20200331.xml EX-101.INS 666942
7 XBRL TAXONOMY EXTENSION SCHEMA aqst-20200331.xsd EX-101.SCH 53638
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aqst-20200331_cal.xml EX-101.CAL 55952
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aqst-20200331_def.xml EX-101.DEF 241161
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aqst-20200331_lab.xml EX-101.LAB 680980
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aqst-20200331_pre.xml EX-101.PRE 386682
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38599 | Film No.: 20849183
SIC: 2834 Pharmaceutical Preparations